Pharma Focus Asia

Natco Pharma Gains on Sale of Non-Core Business in US

Thursday, March 31, 2016

Shares of Natco Pharma were up 4% at Rs 415 on the Bombay Stock Exchange on plans to sell-off its non-core business.

The company in a release said, the board of directors at its meeting held on March 30, 2016 approved the sale of Save Mart Pharmacy Stores located in USA which is non-core business.

The Save Mart Pharmacy Stores is being owned by Natco Pharma Inc., a wholly-owned subsidiary of the company, the release added.

The stock opened at Rs 405 and touched a high of Rs 425. At 12:25pm, over 1.48 million shares were traded on both the stock exchanges.

 

Source : business-standard.com

Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024